Philip S. Low Ph.D.

Philip S. Low Ph.D.

Chief Scientific Officer at On Target Laboratories

Are you Philip S. Low Ph.D.? Claim your profile
 
  • IDENTIFY executive and board member connections in Philip S. Low Ph.D.'s network.
  • FOLLOW changes in Philip S. Low Ph.D.'s employment.
  • CONNECT with Philip S. Low Ph.D. through your network of contacts.

Philip S. Low Ph.D.'s Executive Work History


Current
Board Member,
Board Member
Equilar on 02/17/2022
MorphImmune Inc.
Advisor,
Advisor
Equilar on 05/20/2022
Aro Biotherapeutics Co
Advisor,
Advisor
Equilar on 10/19/2022
Umoja Biopharma, Inc.
Chief Scientific Officer,
Chief Scientific Officer
Equilar on 10/16/2020
On Target Laboratories
Board Member,
Board Member
Equilar on 06/24/2021
Umoja Biopharma, Inc.
Past
To view Philip S. Low Ph.D.'s complete executive work history,
Education
B.S., Brigham Young University
Ph.D., University of California, San Diego
Age
74
 

Philip S. Low Ph.D.'s Biography


Dr. Low is a co-founder of Umoja Biopharma and co-chair of the Scientific Advisory Board. He is the Presidential Scholar in Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. Dr. Low has spent over 30 years exploring novel methods for targeted drug discovery, including target identification, drug design and synthesis, animal testing, and human clinical evaluation. He has published more than 500 scientific articles and has over 100 U.S. patents/patents pending. Eight drugs stemming from his research are undergoing human clinical trials and seven companies (Endocyte Inc., OnTarget Laboratories Inc., Novosteo Inc., Erythrocure Inc., Umoja Biopharma Inc., Morphimmune Inc. and Eradivir Inc.) have been founded to commercialize these discoveries. Dr. Low has received an NIH MERIT Award, the ACS Award for Cancer Research (Sosnovsky Award), the AACR Award for Outstanding Chemistry in Cancer Research, both of Purdue’s awards for outstanding research (McCoy and Sigma Xi Awards), the University’s highest career achievement award (Morrill Award), and numerous other National and International awards. Dr. Low received his B.S. in Chemistry from Brigham Young University (1971) and his Ph.D. in Biochemistry from UCSD (1975). Additional details on Dr. Low’s research can be found at https://www.chem.purdue.edu/people/profile/plow

Source: Umoja Biopharma, Inc. on 10/19/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Philip S. Low Ph.D.. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Philip S. Low Ph.D.'s network.
  • FOLLOW changes in Philip S. Low Ph.D.'s employment.
  • CONNECT with Philip S. Low Ph.D. through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: Philip S. Low Ph.D.

Philip S. Low Ph.D.'s Connections (74)


Allen R. Ritter
Head of CMC, ConSynance Therapeutics
Nushmia Khokhar M.D.
Chief Medical Officer, Pyramid Biosciences, Inc.
Samantha O’Hara
Principal Scientist, Umoja Biopharma, Inc.
James Samuel Shannon M.D.
Board Member, ProQR Therapeutics N.V.
Ann F. Hanham Ph.D.
Chairman, HTG Molecular Diagnostics, Inc.
V. Kadir Kadhiresan
Vice President, Venture Investments, Johnson & Johnson Innovation, LLC
Dawn A. Svoronos
Board Member, Adverum Biotechnologies, Inc.
Dr. Anna Louise French
Board Member, Jasper Therapeutics, Inc.
Marc D. Kozin
Chairman, Vascular Biogenics Ltd.
Dr. Richard A. Messmann
Chief Medical Officer, Apexian Pharmaceuticals, Inc.